Jun 1, 2026 09:00AM
Jun 1, 2026 09:00AM
May 11, 2026 09:02AM
May 11, 2026 09:00AM
May 7, 2026 04:15PM
Apr 6, 2026 09:00AM
Apr 6, 2026 09:00AM Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Mar 30, 2026 09:00AM
Mar 24, 2026 09:00AM
Mar 19, 2026 09:00AM
Feb 26, 2026 04:15PM
Jan 30, 2026 04:09PM
Jan 26, 2026 09:55AM
Jan 26, 2026 09:55AM Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
Jan 23, 2026 02:11PM
Jan 23, 2026 02:10PM
Jan 21, 2026 08:31AM
Jan 21, 2026 08:30AM
Jan 14, 2026 09:00AM
Jan 12, 2026 05:00PM
Jan 7, 2026 09:03AM Revelation Biosciences begins GMP manufacturing of GEMINI drug and placebo
Jan 7, 2026 09:00AM
Dec 1, 2025 09:00AM
Nov 20, 2025 09:01AM
Nov 20, 2025 09:00AM
Nov 6, 2025 04:15PM
Oct 29, 2025 09:00AM
Oct 15, 2025 05:00PM Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025
Sep 30, 2025 06:05AM
Sep 11, 2025 08:32AM
Sep 11, 2025 08:30AM
Sep 10, 2025 07:23AM
Sep 10, 2025 07:20AM
Sep 9, 2025 04:56PM
Sep 9, 2025 04:55PM Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data
Sep 9, 2025 08:14AM
Sep 9, 2025 08:00AM
Jul 1, 2025 05:26PM
May 29, 2025 08:01AM
May 23, 2025 04:07PM
May 9, 2025 07:08AM
Jan 24, 2025 06:05AM Revelation Biosciences (REVB) Announces 1:16 Reverse Share Split
Dec 19, 2024 04:19PM
Dec 3, 2024 08:38AM
Dec 2, 2024 06:00AM
Sep 3, 2024 05:12PM
Jul 19, 2024 04:04PM
Jun 25, 2024 05:09AM
Jun 24, 2024 09:02AM Revelation Biosciences (REVB) Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

413,532 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All